ARTICLE | Company News
OraVax, bioMerieux Vitek Inc. deal
November 18, 1996 8:00 AM UTC
bioMerieux received an exclusive worldwide license (except Japan) to develop in vitro diagnostics using CagA, an antigen component used in ORVX's H. pylori vaccines. ORVX will be eligible for royalti...